Scientists have created a super-map of the brain containing 30 million cells to trace the prenatal origins of diseases.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, announced today ...

As I enter deep middle age, parenting two teenagers, I find reading about brain development more interesting. The old-school view of becoming an adult at 18 (or 21) seems simple. The more recent ...

The potential benefits of organoids for fundamental research and medicine are huge. Efforts to establish proper boundaries ...

The next surprise was that human organoids just kept growing. Mouse organoids were done with making neurons within nine days.

BDTX spotlights silevertinib's 86% CNS response in NSCLC, with 2026 durability data and a glioblastoma push shaping its brain-metastasis strategy.

Researchers at Baylor College of Medicine have uncovered a previously unrecognized mechanism by which inherited calcium ...

A collaborative research study co-led by scientists at the Icahn School of Medicine at Mount Sinai and the Liber Institute ...

Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...

Serina Therapeutics, a clinical-stage biotechnology company specializing in CNS therapeutics, announced the appointment of Dr. Stephen Brannan to its Board of Directors. With over 30 years of ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...